Palantir Technologies Inc. CapEx decreased by 44.2% to $7.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.7%, from $6.18M to $7.40M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 28.0% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $697.00K | $5.38M | $5.84M | $15.22M | $5.46M | $14.44M | $4.92M | $4.76M | $3.93M | $1.57M | $4.86M | $2.66M | $2.88M | $3.99M | $3.11M | $6.18M | $7.63M | $6.79M | $13.27M | $7.40M |
| QoQ Change | — | +671.6% | +8.7% | +160.4% | -64.1% | +164.5% | -65.9% | -3.3% | -17.3% | -60.2% | +210.5% | -45.2% | +8.1% | +38.4% | -22.1% | +99.1% | +23.4% | -11.0% | +95.4% | -44.2% |
| YoY Change | — | — | — | — | +683.1% | +168.4% | -15.8% | -68.7% | -27.9% | -89.2% | -1.2% | -44.0% | -26.8% | +154.6% | -36.1% | +132.1% | +165.2% | +70.4% | +327.3% | +19.7% |